Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
77
JNJ Quote, Financials, Valuation and Earnings
Last price:
$243.43
Seasonality move
:
4.26%
Day range:
$242.61 - $244.95
52-week range:
$141.50 - $246.35
Dividend yield:
2.11%
P/E ratio:
22.04x
P/S ratio:
6.27x
P/B ratio:
7.19x
Volume:
13.3M
Avg. volume:
9.4M
1-year change:
54.82%
Market cap:
$586.7B
Revenue:
$94.2B
EPS (TTM):
$11.05
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $93.8B | $80.1B | $85.2B | $88.8B | $94.2B | |
| Revenue Growth (YoY) | 13.55% | -14.61% | 6.36% | 4.31% | 6.03% | |
| Cost of Revenues | $29.9B | $24.3B | $26.4B | $27.9B | $29.6B | |
| Gross Profit | $63.9B | $55.7B | $58.7B | $61B | $64.6B | |
| Gross Profit Margin | 68.14% | 69.62% | 68.96% | 68.63% | 68.62% | |
| R&D Expenses | $14.7B | $14.3B | $15B | $17.3B | $14.8B | |
| Selling, General & Admin | $24.7B | $20.2B | $21.5B | $22.9B | $23.7B | |
| Other Inc / (Exp) | -$1.6B | -$1.9B | -$8.8B | -$6B | -- | |
| Operating Expenses | $39.4B | $34.5B | $36.6B | $40.1B | $38.5B | |
| Operating Income | $24.5B | $21.2B | $22.2B | $20.8B | $26.1B | |
| Net Interest Expenses | $759M | $841M | $1.2B | $1.2B | $1.5B | |
| EBT. Incl. Unusual Items | $22.8B | $19.4B | $15.1B | $16.7B | $32.6B | |
| Earnings of Discontinued Ops. | -- | $1.6B | $21.8B | -- | -- | |
| Income Tax Expense | $1.9B | $3B | $1.7B | $2.6B | $5.8B | |
| Net Income to Company | $20.9B | $17.9B | $35.2B | $14.1B | $26.8B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $20.9B | $16.4B | $13.3B | $14.1B | $26.8B | |
| Basic EPS (Cont. Ops) | $7.93 | $6.83 | $5.59 | $5.84 | $11.13 | |
| Diluted EPS (Cont. Ops) | $7.81 | $6.73 | $5.53 | $5.79 | $11.03 | |
| Weighted Average Basic Share | $2.6B | $2.6B | $2.5B | $2.4B | $2.4B | |
| Weighted Average Diluted Share | $2.7B | $2.7B | $2.6B | $2.4B | $2.4B | |
| EBITDA | $31.9B | $28.2B | $29.6B | $28.2B | $33.6B | |
| EBIT | $24.5B | $21.2B | $22.2B | $20.8B | $26.1B | |
| Revenue (Reported) | $93.8B | $80.1B | $85.2B | $88.8B | $94.2B | |
| Operating Income (Reported) | $24.5B | $21.2B | $22.2B | $20.8B | $26.1B | |
| Operating Income (Adjusted) | $24.5B | $21.2B | $22.2B | $20.8B | $26.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $24.8B | $20B | $21.4B | $22.5B | $24.6B | |
| Revenue Growth (YoY) | 10.41% | -19.57% | 7.19% | 5.27% | 9.07% | |
| Cost of Revenues | $8.1B | $6B | $6.9B | $7.2B | $8.2B | |
| Gross Profit | $16.7B | $14B | $14.5B | $15.3B | $16.4B | |
| Gross Profit Margin | 67.17% | 70.17% | 67.68% | 67.89% | 66.77% | |
| R&D Expenses | $4.7B | $3.7B | $4.5B | $5.3B | $4.3B | |
| Selling, General & Admin | $7.2B | $5.3B | $5.8B | $6.5B | $6.8B | |
| Other Inc / (Exp) | $434M | -$158M | -$4M | -$59M | -- | |
| Operating Expenses | $11.9B | $9.1B | $10.3B | $11.8B | $11B | |
| Operating Income | $4.8B | $4.9B | $4.2B | $3.5B | $5.4B | |
| Net Interest Expenses | $158M | $298M | $235M | $268M | $490M | |
| EBT. Incl. Unusual Items | $4.8B | $3.8B | $4.8B | $3.9B | $5B | |
| Earnings of Discontinued Ops. | -- | $293M | -$83M | -- | -- | |
| Income Tax Expense | $100M | $613M | $694M | $456M | -$150M | |
| Net Income to Company | $4.7B | $3.5B | $4B | $3.4B | $5.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $4.7B | $3.2B | $4.1B | $3.4B | $5.1B | |
| Basic EPS (Cont. Ops) | $1.80 | $1.35 | $1.68 | $1.43 | $2.12 | |
| Diluted EPS (Cont. Ops) | $1.77 | $1.33 | $1.67 | $1.41 | $2.10 | |
| Weighted Average Basic Share | $2.6B | $2.6B | $2.4B | $2.4B | $2.4B | |
| Weighted Average Diluted Share | $2.7B | $2.7B | $2.4B | $2.4B | $2.4B | |
| EBITDA | $6.6B | $6.7B | $6B | $5.4B | $7.4B | |
| EBIT | $4.8B | $4.9B | $4.2B | $3.5B | $5.4B | |
| Revenue (Reported) | $24.8B | $20B | $21.4B | $22.5B | $24.6B | |
| Operating Income (Reported) | $4.8B | $4.9B | $4.2B | $3.5B | $5.4B | |
| Operating Income (Adjusted) | $4.8B | $4.9B | $4.2B | $3.5B | $5.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $93.8B | $87.5B | $85.2B | $88.8B | $94.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $29.9B | $27.5B | $26.5B | $27.8B | $30.2B | |
| Gross Profit | $63.9B | $60B | $58.7B | $61B | $64B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $14.5B | $14.5B | $15B | $17.3B | $14.7B | |
| Selling, General & Admin | $24.7B | $22.5B | $21.5B | $22.9B | $23.7B | |
| Other Inc / (Exp) | -$1.6B | -$1.7B | -$8.8B | -$5.9B | -- | |
| Operating Expenses | $39.2B | $37B | $36.6B | $40.1B | $38.4B | |
| Operating Income | $24.7B | $23B | $22.1B | $20.9B | $25.6B | |
| Net Interest Expenses | $715M | $943M | $1.2B | $1.2B | $1.6B | |
| EBT. Incl. Unusual Items | $22.8B | $20.7B | $15.1B | $16.7B | $32.6B | |
| Earnings of Discontinued Ops. | -- | $441M | $21.8B | -- | -- | |
| Income Tax Expense | $1.9B | $3.2B | $1.7B | $2.6B | $5.8B | |
| Net Income to Company | $20.9B | $17.9B | $35.2B | $14.1B | $26.8B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $20.9B | $17.5B | $13.3B | $14.1B | $26.8B | |
| Basic EPS (Cont. Ops) | $7.93 | $6.83 | $5.64 | $5.84 | $11.13 | |
| Diluted EPS (Cont. Ops) | $7.81 | $6.74 | $5.58 | $5.80 | $11.05 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $32.1B | $30B | $29.4B | $28.2B | $33.1B | |
| EBIT | $24.7B | $23B | $22.1B | $20.9B | $25.6B | |
| Revenue (Reported) | $93.8B | $87.5B | $85.2B | $88.8B | $94.2B | |
| Operating Income (Reported) | $24.7B | $23B | $22.1B | $20.9B | $25.6B | |
| Operating Income (Adjusted) | $24.7B | $23B | $22.1B | $20.9B | $25.6B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $87.5B | $85.2B | $88.8B | $94.2B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $27.5B | $26.5B | $27.8B | $30.2B | -- | |
| Gross Profit | $60B | $58.7B | $61B | $64B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $14.5B | $15B | $17.3B | $14.7B | -- | |
| Selling, General & Admin | $22.5B | $21.5B | $22.9B | $23.7B | -- | |
| Other Inc / (Exp) | -$1.7B | -$8.8B | -$5.9B | $6.9B | -- | |
| Operating Expenses | $37B | $36.6B | $40.1B | $38.4B | -- | |
| Operating Income | $23B | $22.1B | $20.9B | $25.6B | -- | |
| Net Interest Expenses | $943M | $1.2B | $1.2B | $1.6B | -- | |
| EBT. Incl. Unusual Items | $20.7B | $15.1B | $16.7B | $32.6B | -- | |
| Earnings of Discontinued Ops. | $441M | $21.8B | -- | -- | -- | |
| Income Tax Expense | $3.2B | $1.7B | $2.6B | $5.8B | -- | |
| Net Income to Company | $17.9B | $35.2B | $14.1B | $26.8B | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $17.5B | $13.3B | $14.1B | $26.8B | -- | |
| Basic EPS (Cont. Ops) | $6.83 | $5.64 | $5.84 | $11.13 | -- | |
| Diluted EPS (Cont. Ops) | $6.74 | $5.58 | $5.80 | $11.05 | -- | |
| Weighted Average Basic Share | $10.5B | $10.1B | $9.6B | $9.6B | -- | |
| Weighted Average Diluted Share | $10.6B | $10.2B | $9.7B | $9.7B | -- | |
| EBITDA | $30B | $29.4B | $28.2B | $33.1B | -- | |
| EBIT | $23B | $22.1B | $20.9B | $25.6B | -- | |
| Revenue (Reported) | $87.5B | $85.2B | $88.8B | $94.2B | -- | |
| Operating Income (Reported) | $23B | $22.1B | $20.9B | $25.6B | -- | |
| Operating Income (Adjusted) | $23B | $22.1B | $20.9B | $25.6B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $31.6B | $22.3B | $22.9B | $24.5B | $20.1B | |
| Short Term Investments | $17.1B | $9.4B | $1.1B | $417M | -- | |
| Accounts Receivable, Net | $15.3B | $14B | $14.9B | $14.8B | $17.2B | |
| Inventory | $10.4B | $10.3B | $11.2B | $12.4B | $14.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $61B | $55.3B | $53.5B | $55.9B | $55.6B | |
| Property Plant And Equipment | $19.9B | $19B | $20.9B | $21.6B | $24.5B | |
| Long-Term Investments | $1.9B | $576M | $4.5B | $451M | $665M | |
| Goodwill | $35.2B | $36B | $36.6B | $44.2B | -- | |
| Other Intangibles | $46.4B | $38.5B | $34.2B | $37.6B | -- | |
| Other Long-Term Assets | $10.2B | $30.6B | $14.2B | $11.4B | -- | |
| Total Assets | $182B | $187.4B | $167.6B | $180.1B | $199.2B | |
| Accounts Payable | $11.1B | $9.9B | $9.6B | $10.3B | $12B | |
| Accrued Expenses | $25.7B | $24.3B | $26.2B | $26.1B | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $3.6B | -- | -- | -- | |
| Total Current Liabilities | $45.2B | $55.8B | $46.3B | $50.3B | $54.1B | |
| Long-Term Debt | $31B | $28B | $27B | $31.9B | $40.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $108B | $110.6B | $98.8B | $108.6B | $117.7B | |
| Common Stock | $3.1B | $3.1B | $3.1B | $3.1B | $3.1B | |
| Other Common Equity Adj | -$13.1B | -$13B | -$12.5B | -$11.7B | -- | |
| Common Equity | $74B | $76.8B | $68.8B | $71.5B | $81.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $74B | $76.8B | $68.8B | $71.5B | $81.5B | |
| Total Liabilities and Equity | $182B | $187.4B | $167.6B | $180.1B | $199.2B | |
| Cash and Short Terms | $31.6B | $22.3B | $22.9B | $24.5B | $20.1B | |
| Total Debt | $33.1B | $28B | $27B | $31.9B | $40.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $31.6B | $22.3B | $22.9B | $24.5B | $20.1B | |
| Short Term Investments | $17.1B | $9.4B | $1.1B | $417M | -- | |
| Accounts Receivable, Net | $15.3B | $14B | $14.9B | $14.8B | $17.2B | |
| Inventory | $10.4B | $10.3B | $11.2B | $12.4B | $14.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $61B | $55.3B | $53.5B | $55.9B | $55.6B | |
| Property Plant And Equipment | $19.9B | $19B | $20.9B | $21.6B | $24.5B | |
| Long-Term Investments | $1.9B | $576M | $4.5B | $451M | $665M | |
| Goodwill | $35.2B | $36B | $36.6B | $44.2B | -- | |
| Other Intangibles | $46.4B | $38.5B | $34.2B | $37.6B | -- | |
| Other Long-Term Assets | $10.2B | $30.6B | $14.2B | $11.4B | -- | |
| Total Assets | $182B | $187.4B | $167.6B | $180.1B | $199.2B | |
| Accounts Payable | $11.1B | $9.9B | $9.6B | $10.3B | $12B | |
| Accrued Expenses | $25.7B | $24.3B | $26.2B | $26.1B | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $3.6B | -- | -- | -- | |
| Total Current Liabilities | $45.2B | $55.8B | $46.3B | $50.3B | $54.1B | |
| Long-Term Debt | $31B | $28B | $27B | $31.9B | $40.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $108B | $110.6B | $98.8B | $108.6B | $117.7B | |
| Common Stock | $3.1B | $3.1B | $3.1B | $3.1B | $3.1B | |
| Other Common Equity Adj | -$13.1B | -$13B | -$12.5B | -$11.7B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $74B | $76.8B | $68.8B | $71.5B | $81.5B | |
| Total Liabilities and Equity | $182B | $187.4B | $167.6B | $180.1B | $199.2B | |
| Cash and Short Terms | $31.6B | $22.3B | $22.9B | $24.5B | $20.1B | |
| Total Debt | $33.1B | $28B | $27B | $31.9B | $40.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $20.9B | $17.9B | $35.2B | $14.1B | $26.8B | |
| Depreciation & Amoritzation | $7.4B | $7B | $7.5B | $7.3B | $7.5B | |
| Stock-Based Compensation | $1.1B | $1.1B | $1.2B | $1.2B | $1.4B | |
| Change in Accounts Receivable | -$2.4B | -$1.3B | -$624M | -$406M | -$1.8B | |
| Change in Inventories | -$1.2B | -$2.5B | -$1.3B | -$1.1B | -$1.5B | |
| Cash From Operations | $23.4B | $21.2B | $22.8B | $24.3B | $24.5B | |
| Capital Expenditures | $3.7B | $4B | $4.5B | $4.4B | $4.8B | |
| Cash Acquisitions | $60M | $17.7B | -- | $15.1B | $17.5B | |
| Cash From Investing | -$8.7B | -$12.4B | $878M | -$18.6B | -$23.6B | |
| Dividends Paid (Ex Special Dividend) | $11B | $11.7B | $11.8B | $11.8B | $12.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2B | $16.1B | $21.8B | $21.9B | -- | |
| Long-Term Debt Repaid | -$3B | -$8.7B | -$24.5B | -$11.9B | -- | |
| Repurchase of Common Stock | $3.5B | $6B | $5.1B | $2.4B | $6B | |
| Other Financing Activities | $395M | $65M | -$1.6B | $234M | -- | |
| Cash From Financing | -$14B | -$8.9B | -$15.8B | -$3.1B | -$5.5B | |
| Beginning Cash (CF) | $14.5B | $12.9B | $21.9B | $24.1B | $19.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $502M | -$360M | $7.7B | $2.2B | -$4.4B | |
| Ending Cash (CF) | $14.8B | $12.2B | $29.5B | $26.1B | $15.5B | |
| Levered Free Cash Flow | $19.8B | $17.2B | $18.2B | $19.8B | $19.7B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.7B | $3.5B | $4B | $3.4B | $5.1B | |
| Depreciation & Amoritzation | $1.8B | $1.8B | $1.8B | $1.9B | $2B | |
| Stock-Based Compensation | $215M | $213M | $178M | $238M | $309M | |
| Change in Accounts Receivable | -$584M | $301M | $227M | $853M | $391M | |
| Change in Inventories | -$70M | -$650M | $124M | -$90M | -$46M | |
| Cash From Operations | $5.7B | $5.4B | $7.9B | $7B | $7.3B | |
| Capital Expenditures | $1.4B | $1.6B | $1.6B | $362M | $1.5B | |
| Cash Acquisitions | $60M | $17.1B | -- | $1M | $3.1B | |
| Cash From Investing | -$5.4B | -$4.4B | -$1.2B | -$1.3B | -$4.5B | |
| Dividends Paid (Ex Special Dividend) | $2.8B | $3B | $2.9B | $3B | $3.1B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $716M | $9B | $1.3B | $3.3B | -- | |
| Long-Term Debt Repaid | -$719M | -$1.7B | -$2.4B | -$1.8B | -- | |
| Repurchase of Common Stock | $996M | $1.3B | $216M | $282M | $1.9B | |
| Other Financing Activities | $126M | -$1.7B | -$665M | $267M | -- | |
| Cash From Financing | -$3.4B | $1.7B | -$4.7B | -$1.3B | -$1.4B | |
| Beginning Cash (CF) | $14.5B | $12.9B | $21.9B | $24.1B | $19.7B | |
| Foreign Exchange Rate Adjustment | -$53M | $119M | $125M | -$198M | $23M | |
| Additions / Reductions | -$3.1B | $2.8B | $2.1B | $4.1B | $1.5B | |
| Ending Cash (CF) | $11.3B | $15.8B | $24.1B | $28B | $21.2B | |
| Levered Free Cash Flow | $4.3B | $3.8B | $6.3B | $6.6B | $5.9B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $20.9B | $17.9B | $35.2B | $14.1B | $26.8B | |
| Depreciation & Amoritzation | $7.4B | $7B | $7.5B | $7.3B | $7.5B | |
| Stock-Based Compensation | $1.1B | $1.1B | $1.2B | $1.2B | $1.4B | |
| Change in Accounts Receivable | -$2.4B | -$1.3B | -$624M | -$406M | -$1.8B | |
| Change in Inventories | -$1.2B | -$2.5B | -$1.3B | -$1.1B | -$1.5B | |
| Cash From Operations | $23.4B | $21.2B | $22.8B | $24.3B | $24.5B | |
| Capital Expenditures | $3.7B | $4B | $4.5B | $4.4B | $4.8B | |
| Cash Acquisitions | $60M | $17.7B | -- | $15.1B | $17.5B | |
| Cash From Investing | -$8.7B | -$12.4B | $878M | -$18.6B | -$23.6B | |
| Dividends Paid (Ex Special Dividend) | $11B | $11.7B | $11.8B | $11.8B | $12.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2B | $16.1B | $21.8B | $21.9B | -- | |
| Long-Term Debt Repaid | -$3B | -$8.7B | -$24.5B | -$11.9B | -- | |
| Repurchase of Common Stock | $3.5B | $6B | $5.1B | $2.4B | $6B | |
| Other Financing Activities | $395M | $65M | -$1.6B | $234M | -- | |
| Cash From Financing | -$14B | -$8.9B | -$15.8B | -$3.1B | -$5.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $502M | -$360M | $7.7B | $2.2B | -$4.4B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $19.8B | $17.2B | $18.2B | $19.8B | $19.7B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $17.9B | $35.2B | $14.1B | $26.8B | -- | |
| Depreciation & Amoritzation | $7B | $7.5B | $7.3B | $7.5B | -- | |
| Stock-Based Compensation | $1.1B | $1.2B | $1.2B | $1.4B | -- | |
| Change in Accounts Receivable | -$1.3B | -$624M | -$406M | -$1.8B | -- | |
| Change in Inventories | -$2.5B | -$1.3B | -$1.1B | -$1.5B | -- | |
| Cash From Operations | $21.2B | $22.8B | $24.3B | $24.5B | -- | |
| Capital Expenditures | $4B | $4.5B | $4.4B | $4.8B | -- | |
| Cash Acquisitions | $17.7B | -- | $15.1B | $17.5B | -- | |
| Cash From Investing | -$12.4B | $878M | -$18.6B | -$23.6B | -- | |
| Dividends Paid (Ex Special Dividend) | $11.7B | $11.8B | $11.8B | $12.4B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $16.1B | $21.8B | $21.9B | $18.5B | -- | |
| Long-Term Debt Repaid | -$8.7B | -$24.5B | -$11.9B | -$5.8B | -- | |
| Repurchase of Common Stock | $6B | $5.1B | $2.4B | $6B | -- | |
| Other Financing Activities | $65M | -$1.6B | $234M | -$230M | -- | |
| Cash From Financing | -$8.9B | -$15.8B | -$3.1B | -$5.5B | -- | |
| Beginning Cash (CF) | $45.7B | $89.6B | $94.4B | $95B | -- | |
| Foreign Exchange Rate Adjustment | -$312M | -$112M | -$289M | $201M | -- | |
| Additions / Reductions | -$360M | $7.7B | $2.2B | -$4.4B | -- | |
| Ending Cash (CF) | $45B | $97.3B | $96.4B | $90.8B | -- | |
| Levered Free Cash Flow | $17.2B | $18.2B | $19.8B | $19.7B | -- | |
Get JNJ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
JNJ
Sector
P/E ratio
22.04x
23.44x
PEG ratio
0.24x
-0.01x
P/B ratio
7.19x
1.73x
Price / LTM sales
6.27x
1.51x
Growth Metrics
JNJ
Sector
Revenue growth
9.07%
3.31%
Earnings growth
48.39%
10.7%
Revenue (5-year growth)
2.67%
6.28%
Earnings forecast
$2.46
-$0.19
Profitability
JNJ
Sector
Profitability FY 2025
$64.6B
$2.6M
Return on invested capital
21.45%
-33.62%
Return on assets
13.97%
-29.74%
Return on equity
34.46%
-39.33%
Earnings Date
Last Earnings Date
Jan
21
Next Earnings Date
Apr
14
Estimated Next Earnings Date
Apr
22
Balance Sheet
JNJ
Sector
Total cash
$20.1B
$25M
Short term investments
$417M
$23.9M
Total assets
$199.2B
$71.9M
Long term debt
$40.8B
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
